Hydroxypyridone iron chelators, L1 and analogues. An 17 O NMR study

Author： Cerioni G.   Plumitallo A.   Batzella M.G.   Locci F.  

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.34, Iss.9, 1999-09, pp. : 759-763

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Design and Development of Deferiprone (L1) and Other Iron Chelators for Clinical Use: Targeting Methods and Application Prospects

By  

Current Medicinal Chemistry, Vol. 11, Iss. 16, 2004-08 ,pp. : 2161-2183

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Iron Overload Therapies. Prospects for Effective Use of Deferiprone (L1), Deferoxamine, the New Experimental Chelators ICL670, GT56-252, L1NAll and their Combinations

By  

Current Medicinal Chemistry, Vol. 12, Iss. 23, 2005-11 ,pp. : 2663-2681

Bentham Science Publishers

Access to resources Recommend Favorite

Iron Chelators for the Treatment of Cancer

By  

Current Medicinal Chemistry, Vol. 19, Iss. 17, 2012-06 ,pp. : 2689-2702

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of iron chelators

By Richardson D.R.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2141-2158

Informa Healthcare

Access to resources Recommend Favorite

Hydroxyquinolines as Iron Chelators

By  

Current Medicinal Chemistry, Vol. 10, Iss. 12, 2003-06 ,pp. : 1077-1084

Bentham Science Publishers

Access to resources Recommend Favorite